glp-1 and ulcerative colitis Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations Practical Recommendations for Safe and Effective Use | Current Obesity Reports Ozempic and Ulcerative Colitis: GLP-1

Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis

Drop back to the previous dose and attempt escalation again after an additional 2-4 weeks

Mechanism of Action BPC-157 (Body Protection Compound) BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice

Klein EA, Thompson IM Jr, Tangen CM, et al

Moderate-to-severe cases may require corticosteroids for acute flares, followed by immunomodulators (azathioprine, 6-mercaptopurine) or biologic agents (anti-TNF therapies, vedolizumab, ustekinumab)

Bioorganic & medicinal chemistry 18, 40424048, 10.1016/j.bmc.2010.04.021 (2010)